Company Profile


BMI focuses on the research of packaging sealing integrity;
Provide overall solutions, including test method development and equipment validation.
BMI detection technology is a deterministic test method to generate quantitative test result data.
BMI provides detection systems for packaging leak testing, seal integrity and container seal integrity testing (CCIT). Our products and technologies exclude subjectivity from packaging test, and make it conform to ASTM standard test methods and FDA standards, and conform to CDE (Technical Guide for Sealing Research of Chemical Injection Packaging System).

Boma Scientific Instrument (Shanghai) Co., Ltd,BMI, for short, is a research and development and production enterprise focusing on the field of medicine and health established in China by Zenith Lab Inc of the United States and China to share technological achievements. Zenith Lab Inc has been developing and manufacturing laboratory automation products&testing instruments in the United States since 1988. It has a history of 33 years. BMI is committed to providing safe and efficient solutions and process optimization for packaging and testing of pharmaceutical products. The cornerstone of BMI's development is the industry's leading technical strength, unparalleled efficiency in China and excellent and fast local services; The main products are used for container closure integrity testing (CCIT).
At present, BMI has two subsidiaries in China, Boma Scientific Instrument (Chongqing) Co., Ltd. and Chongqing Anmu Technology Co., Ltd. As the global technology leader in the field of packaging seal integrity testing, BMI's annual R&D investment is not less than 12% of sales. Currently, BMI has more than 20 patents. At the same time, there are a number of invention&utility model patents under application. The performance of BMI products has been recognized by many users, In particular, it has been affirmed by many packaging material testing centers of provincial drug inspection institutes. At present, China has become the largest emerging market for pharmaceutical products. In the future, BMI will, as always, adhere to the concept of providing customers with "one-stop" overall solutions, help Chinese pharmaceutical enterprises optimize testing processes and improve production efficiency, and ensure that the packaging of each drug in the hands of patients is "impeccable".

 

For more product requirements, please leave us a message to apply for online and offline demonstrations and more product samples!

Submit